Latanoprost/Timolol Omnivision

Timolol maleate and Latanoprost, the active ingredient in Latanoprost/Timolol Omnivision, is a beta‑blocker/prostaglandin analog presented as an ophthalmic solution for ocular use. It is employed to lower intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension, helping to preserve visual function.

GNH USA supplies Latanoprost/Timolol Omnivision as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, regulatory compliance and reliable delivery across global markets.

Latanoprost/Timolol Omnivision is indicated for conditions affecting intra‑ocular pressure within the glaucoma disease family.

- Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers elevated eye pressure to prevent conversion to glaucoma. - Secondary open‑angle glaucoma: helps control pressure when glaucoma is associated with other ocular conditions.

Latanoprost/Timolol Omnivision may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: mild burning or stinging after instillation. - Blurred vision: transient visual disturbance. - Red eye: conjunctival hyperemia. - Itching: peri‑ocular pruritus. - Dry eye: reduced tear production. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or severe itching. - Severe eye pain: intense discomfort requiring medical attention. - Sudden vision loss: abrupt decrease in visual acuity. - Increased intra‑ocular pressure: paradoxical pressure rise. - Corneal edema: swelling of the cornea. - Uveitis: inflammation of the uveal tract.

Before prescribing Latanoprost/Timolol Omnivision, clinicians should consider several safety measures.

- Monitor intra‑ocular pressure: ensure therapeutic response and adjust therapy as needed. - Contraindicated in asthma or severe COPD: beta‑blocker component may exacerbate bronchospasm. - Caution in heart block or bradycardia: systemic absorption can affect cardiac conduction. - Use with caution in severe renal impairment: altered drug clearance may occur. - Avoid in patients with sulfonamide allergy: timolol contains a sulfonamide moiety. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Latanoprost/Timolol Omnivision can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Systemic non‑selective beta‑blockers: additive cardiovascular depression. - Other prostaglandin analog eye drops: excessive ocular irritation. - Adrenergic agonists (e.g., epinephrine): antagonistic effect on intra‑ocular pressure reduction.

Moderate Interactions (Monitor Closely): - Anticholinergic ophthalmic agents: may affect pupil size and ocular comfort. - Carbonic anhydrase inhibitors: potential additive IOP‑lowering effect. - Systemic antihypertensives: monitor blood pressure for additive lowering.